Sex: F
Vaccine: TYP
Symptoms: Abdominal pain upper, Dizziness, Feeding disorder, Loss of personal independence in daily activities, Nausea
Clinical narrative: Trouble in eating; Dizziness; Nausea; Stomach pain; Spontaneous report received on 25FEB2020.  A pharmacist reported that an adult female consumer (college aged) had nausea (PT: Nausea), stomach pain (PT: Abdominal pain upper), dizziness (PT: Dizziness), trouble in eating (PT: Feeding disorder) and trouble with school (PT: Educational problem) while being on Vivotif for immunisation. The consumer took her first two doses of Vivotif on an unknown date. Later, it was reported that she had nausea, stomach pain, dizziness, trouble in eating, and trouble with school. Action taken with Vivotif with respect to the reported events was unknown. The outcome of the reported events was unknown at the time of report.  Company Comment: An adult consumer took first two doses of Vivotif and then had nausea, abdominal pain upper, dizziness, trouble in eating (unable to eat) and trouble with school (educational problem). Information on medical history, further details of the events, and action taken with Vivotif is limited. Considering the potential of Vivotif to cause nausea, abdominal pain, dizziness, and case information, the causality of nausea, dizziness and abdominal pain upper is assessed as possible with Vivotif. In this case, the event nausea might have caused the event, unable to eat, and all these events might have caused educational problem, and the causality of unable to eat and educational problem is assessed as possible with Vivotif.  Follow up information received on 01JUN2020 from the reporter healthcare professional regarding dates of Vivotif and events.  It was updated that the consumer having normal body mass index (BMI).  It was updated that the consumer started Vivotif on 22FEB2020. It was reported that the consumer had some reaction (unspecified) between third and fourth dose. Thus, her pharmacist advised to take remaining doses of Vivotif in the evening (before bedtime) and the consumer completed all the remaining doses of Vivotif.  Action taken with Vivotif with respect to the events was updated to dose not changed.  Additionally, it was reported that the consumer missed some classes because of the previously reported events. Hence, the previously reported event "trouble with school" will be deleted.  Company Comment: An adult consumer took first two doses of vivotif and then had nausea, abdominal pain upper, dizziness, trouble in eating (unable to eat) due to which she missed some classes at school. In response to the events, she took remaining doses in the evening and further details of the events is limited. Considering the potential of vivotif to cause nausea, abdominal pain, dizziness, and case information, the causality of nausea, dizziness and abdominal pain upper is assessed as possible with vivotif. In this case, the event nausea might have caused the event (unable to eat), and the causality of unable to eat is assessed as possible with vivotif.; Sender's Comments: An adult consumer took first two doses of vivotif and then had nausea, abdominal pain upper, dizziness, trouble in eating (unable to eat) due to which she missed some classes at school. In response to the events, she took remaining doses in the evening and further details of the events is limited. Considering the potential of vivotif to cause nausea, abdominal pain, dizziness, and case information, the causality of nausea, dizziness and abdominal pain upper is assessed as possible with vivotif. In this case, the event nausea might have caused the event (unable to eat), and the causality of unable to eat is assessed as possible with vivotif.